A new artificial intelligence-based method accurately sorts cancer patients into groups that have similar characteristics before treatment and similar outcomes after treatment, according to a study led by investigators at ...
May 12, 2025
0
16
Just as species adapt over generations, our body's cells accumulate DNA changes throughout life. Most are harmless, yet a few "driver" mutations give a cell a competitive edge and can spark cancer. Chemotherapy then adds ...
May 13, 2025
0
7
Researchers from USask have identified a potential target for eliminating breast cancer cells. The team was led by Dr. Franco Vizeacoumar (Ph.D.) and Dr. Andrew Freywald (Ph.D.) with USask and the Saskatchewan Cancer Agency.
13 hours ago
0
1
Colorectal cancer is the second leading cause of cancer-related death globally. Although some of the molecular changes associated with colorectal cancer are known, how they contribute to cancer development is not yet well ...
May 13, 2025
0
1
A new trial of patients with advanced rectal cancer has found that the addition of immunotherapy treatment alongside extended radiotherapy led to better rates of remission.
May 9, 2025
0
0
Immunotherapy uses a person's own immune system to fight cancer. Immune checkpoint inhibitors are one class of immunotherapy that block specific proteins from slowing the immune response. As a result, immune cells become ...
May 14, 2025
0
9
A review now published in the Journal of Experimental & Clinical Cancer Research offers a sweeping and authoritative synthesis of the use of liquid biopsy in gynecological oncology, placing this emerging tool at the forefront ...
May 9, 2025
0
0
Researchers have sought to improve our understanding of why Aboriginal and Torres Strait Islander women (respectfully referred to hereon as Aboriginal) with breast cancer can have poorer outcomes than non-Aboriginal women.
May 9, 2025
0
10
In one of the larger studies of its kind, researchers have identified six breast texture patterns that may be associated with increased cancer risk, according to a study published in Radiology.
May 13, 2025
0
1
An innovative blood cancer treatment regimen could extend remission by seven months on average, according to a clinical trial led by the University of Leeds.
22 hours ago
0
10
